Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. / Skovbro, M; Baranowski, M; Skov-Jensen, C; Flint, A; Dela, F; Gorski, J; Helge, J W.

I: Diabetologia, Bind 51, Nr. 7, 2008, s. 1253-60.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Skovbro, M, Baranowski, M, Skov-Jensen, C, Flint, A, Dela, F, Gorski, J & Helge, JW 2008, 'Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity', Diabetologia, bind 51, nr. 7, s. 1253-60. https://doi.org/10.1007/s00125-008-1014-z

APA

Skovbro, M., Baranowski, M., Skov-Jensen, C., Flint, A., Dela, F., Gorski, J., & Helge, J. W. (2008). Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia, 51(7), 1253-60. https://doi.org/10.1007/s00125-008-1014-z

Vancouver

Skovbro M, Baranowski M, Skov-Jensen C, Flint A, Dela F, Gorski J o.a. Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia. 2008;51(7):1253-60. https://doi.org/10.1007/s00125-008-1014-z

Author

Skovbro, M ; Baranowski, M ; Skov-Jensen, C ; Flint, A ; Dela, F ; Gorski, J ; Helge, J W. / Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. I: Diabetologia. 2008 ; Bind 51, Nr. 7. s. 1253-60.

Bibtex

@article{8851dd00f1f911ddbf70000ea68e967b,
title = "Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity",
abstract = "AIMS/HYPOTHESIS: In skeletal muscle, ceramides may be involved in the pathogenesis of insulin resistance through an attenuation of insulin signalling. This study investigated total skeletal muscle ceramide fatty acid content in participants exhibiting a wide range of insulin sensitivities. METHODS: The middle-aged male participants (n=33) were matched for lean body mass and divided into four groups: type 2 diabetes (T2D, n=8), impaired glucose tolerance (IGT, n=9), healthy controls (CON, n=8) and endurance-trained (TR, n=8). A two step (28 and 80 mU m(-2) min(-1)) sequential euglycaemic-hyperinsulinaemic clamp was performed for 120 and 90 min for step 1 and step 2, respectively. Muscle biopsies were obtained from vastus lateralis at baseline, and after steps 1 and 2. RESULTS: Glucose infusion rates increased in response to insulin infusion, and significant differences were present between groups (T2D",
author = "M Skovbro and M Baranowski and C Skov-Jensen and A Flint and F Dela and J Gorski and Helge, {J W}",
note = "Keywords: Biopsy; Blood Glucose; Ceramides; Diabetes Mellitus, Type 2; Diglycerides; Glucose Clamp Technique; Glucose Intolerance; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Physical Endurance; Triglycerides",
year = "2008",
doi = "10.1007/s00125-008-1014-z",
language = "English",
volume = "51",
pages = "1253--60",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity

AU - Skovbro, M

AU - Baranowski, M

AU - Skov-Jensen, C

AU - Flint, A

AU - Dela, F

AU - Gorski, J

AU - Helge, J W

N1 - Keywords: Biopsy; Blood Glucose; Ceramides; Diabetes Mellitus, Type 2; Diglycerides; Glucose Clamp Technique; Glucose Intolerance; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Physical Endurance; Triglycerides

PY - 2008

Y1 - 2008

N2 - AIMS/HYPOTHESIS: In skeletal muscle, ceramides may be involved in the pathogenesis of insulin resistance through an attenuation of insulin signalling. This study investigated total skeletal muscle ceramide fatty acid content in participants exhibiting a wide range of insulin sensitivities. METHODS: The middle-aged male participants (n=33) were matched for lean body mass and divided into four groups: type 2 diabetes (T2D, n=8), impaired glucose tolerance (IGT, n=9), healthy controls (CON, n=8) and endurance-trained (TR, n=8). A two step (28 and 80 mU m(-2) min(-1)) sequential euglycaemic-hyperinsulinaemic clamp was performed for 120 and 90 min for step 1 and step 2, respectively. Muscle biopsies were obtained from vastus lateralis at baseline, and after steps 1 and 2. RESULTS: Glucose infusion rates increased in response to insulin infusion, and significant differences were present between groups (T2D

AB - AIMS/HYPOTHESIS: In skeletal muscle, ceramides may be involved in the pathogenesis of insulin resistance through an attenuation of insulin signalling. This study investigated total skeletal muscle ceramide fatty acid content in participants exhibiting a wide range of insulin sensitivities. METHODS: The middle-aged male participants (n=33) were matched for lean body mass and divided into four groups: type 2 diabetes (T2D, n=8), impaired glucose tolerance (IGT, n=9), healthy controls (CON, n=8) and endurance-trained (TR, n=8). A two step (28 and 80 mU m(-2) min(-1)) sequential euglycaemic-hyperinsulinaemic clamp was performed for 120 and 90 min for step 1 and step 2, respectively. Muscle biopsies were obtained from vastus lateralis at baseline, and after steps 1 and 2. RESULTS: Glucose infusion rates increased in response to insulin infusion, and significant differences were present between groups (T2D

U2 - 10.1007/s00125-008-1014-z

DO - 10.1007/s00125-008-1014-z

M3 - Journal article

C2 - 18458871

VL - 51

SP - 1253

EP - 1260

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 7

ER -

ID: 10118890